News
Betting on Disruption: Is Lemonade the Future of Insurance?
After a long period of intense volatility, Lemonade, Inc. (NYSE: LMND) is back in the spotlight. The insurance technology company's stock has delivered
Wall Street Sees More Upside for Dell and HPE
Two stocks that are curious cases in tech after recent earnings are Dell Technologies (NYSE: DELL) and Hewlett-Packard Enterprise (NYSE: HPE). As of the June 10 close, Dell and HPE are up 0.5% and
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May
In May, three stocks that released earnings stood out due to their massive sales beats. These names are mid-cap companies with market capitalizations between $2 billion and $10 billion.
Companies
GitLab: Buy It Low While You Still Can—Higher Prices Are Coming
There was absolutely nothing wrong with GitLab’s (NASDAQ: GTLB) Q1 earnings report and guidance. Nothing that is, except a wee bit of tepidness
Why Smart Money Just Bought $1.3B of Altria Stock
This stock may not be part of the most exciting stories in the stock market today, both in terms of its business model and price action. While every investor is watching the developments in the
Why Unity Software May Be the AI Breakout No One Saw Coming
The technology sector in the United States is a breeding ground for some of the most innovative companies in the world, especially now that advances in artificial intelligence have lowered the
Five Below Pops on Strong Earnings, But Rally May Stall
Off-price retail stocks have had a good week, and Five Below Inc. (NASDAQ: FIVE) was no exception. After the market closed on June 4, the company reported strong earnings and raised its full-year
3 Stocks Getting Rare Double Upgrades From Analysts
Markets hate uncertainty, which has been the norm in 2025. Tariffs, interest rates, and inflation are driving analysts’ expectations. However, that can become an opportunity for nimble investors
This Banking Giant Just Got a $90 Price Target Upgrade
When it comes to the financial sector, understanding the underlying impact of bank balance sheets and key performance indicators (KPIs) can be a daunting task. However, one common indicator is
Breakout Momentum Plays You May Not Know About
High volatility has plagued markets throughout much of 2025. While many consider this a bad thing, particularly when trends point downward, it can also create opportunities for momentum investors
Online Casino ohne Limit: Beste neue Funktion von Rakebit für sofortige Auszahlungen ohne Limits
BERLIN, June 06, 2025 (GLOBE NEWSWIRE) -- Rakebit, eines der bekanntesten Krypto-Casinos in Europa, startet offiziell seine neue Infrastruktur für sofortige Auszahlungen und setzt damit neue
Online Casino Schnelle Auszahlung: Rakebit als bestes Krypto Casino mit sofortiger Auszahlung & ohne Limit
BERLIN, June 06, 2025 (GLOBE NEWSWIRE) -- Rakebit, eines der führenden Krypto-Casinos Europas, kündigt heute den offiziellen Start seiner neuen Sofortauszahlungs-Infrastruktur an. Die Plattform
5 Earnings Season Winners With More Upside on the Way
Earnings season has come and gone, and many prominent companies surprised analysts with impressive Q1 earnings strength. Despite unpredictable tariffs, a weakening dollar, and ISM survey comments
BrainChip Aktie: Drei Tage Rallye – was steckt dahinter?
Plötzlich geht es wieder bergauf: Die BrainChip-Aktie zeigt seit drei Tagen ungewöhnliche Stärke und…
Der Beitrag BrainChip Aktie: Drei Tage Rallye – was steckt dahinter? erschien zuerst auf kapital
Eutelsat Stock: Korean Partner Exits With Massive Loss
Eutelsat suffered a significant blow as South Korean technology firm Hanwha Systems divested its entire 5.4% stake in the satellite operator at a steep discount. The shares were sold at €3.00 each
A New All-Time High Is Coming Soon for Credo Technology Group
Credo Technology Group’s (NASDAQ: CRDO) stock price surged 25% following its FQ4 earnings release and guidance update, and it will likely set a new
Online Casino ohne Verifizierung: Rakebit setzt neue Standards für Krypto-Spieler
BERLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Rakebit, ein führendes Bitcoin Casino ohne Verifizierung, revolutioniert das Online-Glücksspiel für Krypto-Enthusiasten. In einer Zeit, in der KYC
Red Robin's Comeback: Q1 Earnings Spark Investor Hopes
Red Robin Gourmet Burgers (NASDAQ: RRGB) first-quarter 2025 earnings news in late May caused an all-day rush for the stock, sending shares of the casual
3 Utilities Stocks With Big Earnings, Balanced Risk
Investors often skip over the utilities sector in favor of companies in higher-growth industries. Utilities stocks tend to be stable sources of dividend income and defensive plays. With all of the
Robinhood Stock Keeps Giving Investors Reasons To Buy
Shares of Robinhood Markets Inc. (NASDAQ: HOOD) have been one of the most exciting stories in the financial sector, as the company that has single-handedly done the most to democratize markets and
Analog Devices' Cyclical Recovery Story Has Just Begun
Analog Devices’ (NASDAQ: ADI) FQ2 2025 earnings report and guidance update reads like a textbook example of a bull-case scenario for semiconductor stocks. The company’s CEO cited strength in all
Fabriq sichert sich aus einer Finanzierungsrunde über 22 Mio. € Kapital und ebnet damit den Weg, weltweit zum Standard für industrielle Performance zu werden.
Fabriq sichert sich aus einer Finanzierungsrunde über 22 Mio. € Kapital und ebnet damit den Weg, weltweit zum Standard für industrielle Performance zu werden.
Indem das Scale-up Lean-Management
TotalEnergies SE Stock: UK Renewable Energy Portfolio Expands
The French energy giant TotalEnergies is significantly strengthening its position in the British renewable energy market. On Tuesday, June 3, 2025, the company announced the acquisition of a
Why Super Micro Computer's Upside Could Trigger a Short Squeeze
There’s an often forgotten strategy that has made millionaires in the past, when it comes to the stock market, signs of interest (or lack thereof) for any stock can guide regular investors into
Sanofi Stock: $9.1 Billion Blueprint Deal Sparks Debate
The French pharmaceutical giant Sanofi has announced plans to acquire US-based Blueprint Medicines for $9.1 billion, marking a strategic push into the specialized immunology market. The ambitious




